FDA Warns Consumers About Limbrel After Liver and Lung Injury Reports

By |January 30th, 2018|Dangerous Drugs|0 Comments

The U.S. Food and Drug Administration (FDA) has issued a safety warning to consumers regarding Limbrel, a “medical food” product marketed to “manage the metabolic processes associated with osteoarthritis,” because of an increase in adverse event reports of drug-induced liver injury and a lung infection associated with the product. The FDA advises consumers to stop taking Limbrel and contact their doctor. The FDA also advises health care providers who know that their patients are taking [...]